Invesco Biotechnology & Genome ETF
PBE
PBE
81 hedge funds and large institutions have $80.7M invested in Invesco Biotechnology & Genome ETF in 2019 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 16 increasing their positions, 23 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
30% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 23
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
81
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$4.38M | |
| 2 | +$1.62M | |
| 3 | +$594K | |
| 4 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
+$468K |
| 5 |
CA
Calton & Associates
Tampa,
Florida
|
+$314K |
Top Sellers
| 1 | -$12.8M | |
| 2 | -$329K | |
| 3 | -$255K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$255K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
-$145K |